Efficacy and safety of ticagrelor versus clopidogrel with different dosage in high-risk patients with acute coronary syndrome.
Published Feb 1, 2017 · Y. Xin, Hai-shan Zhang, Yu-ze Li
International journal of cardiology
22
Citations
1
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayTicagrelor significantly reduces in-stent thrombosis and thrombus formation in high-risk patients with acute coronary syndrome undergoing PCI, without increasing overall major bleeding but increasing minor bleeding.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.